BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 31058108)

  • 1. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging.
    Hako R; Kristian P; Jarčuška P; Haková I; Hockicková I; Schréter I; Janičko M
    Can J Gastroenterol Hepatol; 2019; 2019():3024630. PubMed ID: 31058108
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.
    Pan S; Wang XQ; Guo QY
    World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J
    Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver.
    Okada M; Murakami T; Yada N; Numata K; Onoda M; Hyodo T; Inoue T; Ishii K; Kudo M
    J Magn Reson Imaging; 2015 Feb; 41(2):329-38. PubMed ID: 24343840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI.
    Jang YJ; Cho SH; Bae JH; Kim GC; Ryeom H; Kim HJ; Shin KM; Lee HJ
    Ann Hepatol; 2013; 12(6):926-34. PubMed ID: 24114823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C.
    Bohte AE; de Niet A; Jansen L; Bipat S; Nederveen AJ; Verheij J; Terpstra V; Sinkus R; van Nieuwkerk KM; de Knegt RJ; Baak BC; Jansen PL; Reesink HW; Stoker J
    Eur Radiol; 2014 Mar; 24(3):638-48. PubMed ID: 24158528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on diagnostic value of extracellular volume imaging by magnetic resonance imaging for liver fibrosis of hepatitis B].
    Sheng RF; Jin KP; Wang HQ; Ji Y; Chen CZ; Zeng MS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):650-653. PubMed ID: 30481860
    [No Abstract]   [Full Text] [Related]  

  • 9. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI.
    Kim SW; Kim YR; Choi KH; Cho EY; Song JS; Kim JE; Kim TH; Lee YH; Yoon KH
    AJR Am J Roentgenol; 2020 Sep; 215(3):624-630. PubMed ID: 32755157
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis.
    Wu WP; Hoi CI; Chen RC; Lin CP; Chou CT
    Medicine (Baltimore); 2017 Oct; 96(42):e8339. PubMed ID: 29049250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.
    Gaia S; Campion D; Evangelista A; Spandre M; Cosso L; Brunello F; Ciccone G; Bugianesi E; Rizzetto M
    Liver Int; 2015 Aug; 35(8):2027-35. PubMed ID: 25495478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits.
    Liu HF; Wang Q; Du YN; Zhu ZH; Li YF; Zou LQ; Xing W
    Magn Reson Imaging; 2020 Jul; 70():57-63. PubMed ID: 32325235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadoxetate-disodium-enhanced magnetic resonance imaging for liver fibrosis staging: a systematic review and meta-analysis.
    Li X; Liu H; Wang R; Yang J; Zhang Y; Li C
    Clin Radiol; 2020 Apr; 75(4):319.e11-319.e19. PubMed ID: 31831141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
    J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive evaluation of hepatic fibrosis in hepatitis C virus-infected patients using ethoxybenzyl-magnetic resonance imaging.
    Nojiri S; Kusakabe A; Fujiwara K; Shinkai N; Matsuura K; Iio E; Miyaki T; Joh T
    J Gastroenterol Hepatol; 2013 Jun; 28(6):1032-9. PubMed ID: 23432660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats.
    Zhang W; Kong X; Wang ZJ; Luo S; Huang W; Zhang LJ
    PLoS One; 2015; 10(6):e0129621. PubMed ID: 26076199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images.
    Yasaka K; Akai H; Kunimatsu A; Abe O; Kiryu S
    Radiology; 2018 Apr; 287(1):146-155. PubMed ID: 29239710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease.
    Hayashi T; Saitoh S; Fukuzawa K; Tsuji Y; Takahashi J; Kawamura Y; Akuta N; Kobayashi M; Ikeda K; Fujii T; Miyati T; Kumada H
    Gut Liver; 2017 Sep; 11(5):674-683. PubMed ID: 28651300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining
    Pan S; Wang L; Xin J
    Life Sci; 2021 Mar; 269():119086. PubMed ID: 33476634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.